Compare Stocks: XTNT, FOCL, ZJYL, and CNXU

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNXU Conexeu Sciences	$4.96 -6.4%	$7.56	$4.19 ▼ $18.79	$139.91M	N/A	229,000 shs	608,439 shs
FOCL FocalTherics	$4.15 -3.0%	$4.99	$1.75 ▼ $6.40	$155.74M	-0.07	78,728 shs	104,833 shs
XTNT Xtant Medical	$0.32 -2.1%	$0.38	$0.27 ▼ $0.95	$44.89M	-0.15	4.96 million shs	199,290 shs
ZJYL Jin Medical International	$1.99 +0.5%	$2.33	$1.53 ▼ $12.00	$156.08M	7.31	127,368 shs	7,965 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNXU Conexeu Sciences	0.00%	+11.21%	-47.40%	-62.65%	+495,999,900.00%
FOCL FocalTherics	0.00%	+1.22%	-2.12%	-13.72%	+414,999,900.00%
XTNT Xtant Medical	0.00%	-8.57%	-3.99%	-27.37%	-50.77%
ZJYL Jin Medical International	0.00%	-3.86%	-34.32%	-19.76%	-83.02%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNXU Conexeu Sciences	$4.96 -6.4%	$7.56	$4.19 ▼ $18.79	$139.91M	N/A	229,000 shs	608,439 shs
FOCL FocalTherics	$4.15 -3.0%	$4.99	$1.75 ▼ $6.40	$155.74M	-0.07	78,728 shs	104,833 shs
XTNT Xtant Medical	$0.32 -2.1%	$0.38	$0.27 ▼ $0.95	$44.89M	-0.15	4.96 million shs	199,290 shs
ZJYL Jin Medical International	$1.99 +0.5%	$2.33	$1.53 ▼ $12.00	$156.08M	7.31	127,368 shs	7,965 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNXU Conexeu Sciences	0.00%	+11.21%	-47.40%	-62.65%	+495,999,900.00%
FOCL FocalTherics	0.00%	+1.22%	-2.12%	-13.72%	+414,999,900.00%
XTNT Xtant Medical	0.00%	-8.57%	-3.99%	-27.37%	-50.77%
ZJYL Jin Medical International	0.00%	-3.86%	-34.32%	-19.76%	-83.02%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNXU Conexeu Sciences	2.00	Hold	$20.00	303.23% Upside
FOCL FocalTherics	2.40	Hold	$7.75	86.75% Upside
XTNT Xtant Medical	3.00	Buy	$1.00	212.50% Upside
ZJYL Jin Medical International	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest XTNT, FOCL, ZJYL, and CNXU Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/2/2026	XTNT Xtant Medical	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$1.00
8/25/2026	FOCL FocalTherics	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$10.00
8/17/2026	CNXU Conexeu Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sell (E-)
8/17/2026	FOCL FocalTherics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/14/2026	FOCL FocalTherics	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$4.00
7/17/2026	FOCL FocalTherics	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Outperform	$15.00
7/17/2026	FOCL FocalTherics	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy
6/29/2026	ZJYL Jin Medical International	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
6/29/2026	CNXU Conexeu Sciences	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
6/22/2026	CNXU Conexeu Sciences	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$20.00

(Data available from 9/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	$0.21 per share	N/A
FOCL FocalTherics	$70.53M	2.21	N/A	N/A	$0.52 per share	7.98
XTNT Xtant Medical	$133.93M	0.34	$0.07 per share	4.39	$0.36 per share	0.89
ZJYL Jin Medical International	$20.69M	7.54	$0.18 per share	10.86	$3.78 per share	0.53

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNXU Conexeu Sciences	-$3.92M	-$0.11	N/A	N/A	N/A	N/A	-200.20%	-177.26%	N/A
FOCL FocalTherics	-$29.25M	-$1.03	N/A	N/A	N/A	-56.26%	-248.00%	-44.69%	N/A
XTNT Xtant Medical	$4.97M	-$0.13	N/A	N/A	N/A	-10.17%	-23.45%	-12.44%	11/10/2026 (Estimated)
ZJYL Jin Medical International	$1.19M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest XTNT, FOCL, ZJYL, and CNXU Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/14/2026	Q3 2026	CNXU Conexeu Sciences	-$0.10	-$0.29	-$0.19	-$0.29	N/A	N/A
8/14/2026	Q2 2026	FOCL FocalTherics	-$0.20	-$0.39	-$0.19	-$0.39	N/A	$13.20 million
8/11/2026	Q2 2026	XTNT Xtant Medical	-$0.02	-$0.07	-$0.05	-$0.07	$24.88 million	$23.03 million
8/4/2026	Q2 2026	ZJYL Jin Medical International	N/A	-$0.01	N/A	-$0.0050	N/A	$4.46 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
FOCL FocalTherics	N/A	N/A	N/A	N/A	N/A
XTNT Xtant Medical	N/A	N/A	N/A	N/A	N/A
ZJYL Jin Medical International	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNXU Conexeu Sciences	N/A	5.31	14.93
FOCL FocalTherics	1.79	1.60	1.38
XTNT Xtant Medical	0.18	2.16	1.05
ZJYL Jin Medical International	0.10	1.95	1.70

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNXU Conexeu Sciences	N/A
FOCL FocalTherics	62.74%
XTNT Xtant Medical	69.33%
ZJYL Jin Medical International	N/A

Insider Ownership

Company	Insider Ownership
CNXU Conexeu Sciences	N/A
FOCL FocalTherics	10.10%
XTNT Xtant Medical	10.70%
ZJYL Jin Medical International	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNXU Conexeu Sciences	4	28.21 million	N/A	N/A
FOCL FocalTherics	230	37.53 million	33.74 million	N/A
XTNT Xtant Medical	151	140.29 million	125.28 million	Not Optionable
ZJYL Jin Medical International	273	78.43 million	N/A	Not Optionable

XTNT, FOCL, ZJYL, and CNXU Headlines

Recent News About These Companies

Jin Medical International Ltd. (NASDAQ:ZJYL) Sees Significant Drop in Short Interest

September 13, 2026 | americanbankingnews.com

Jin Medical International to Acquire Control of Ginseng-Tech Assets via US$159 Million VIE Deal

September 8, 2026 | tipranks.com

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares

August 27, 2026 | livemint.com

Jin Medical International Ltd. Class A

August 6, 2026 | edition.cnn.com

Jin Medical International (ZJYL) stock soars over 63% after hours: Here's what you need to know

August 5, 2026 | msn.com

Jin Medical International Completes VIE Deal and Expands Share Base in July 2026

August 4, 2026 | tipranks.com

JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results

August 4, 2026 | prnewswire.com

Jin Medical International

July 21, 2026 | fool.com

Jin Medical International Restructures Share Classes to Expand Super-Voting Control

July 20, 2026 | tipranks.com

Jin Medical International Earnings Estimates, EPS & Revenue | NASDAQ:ZJYL | Benzinga

July 12, 2026 | benzinga.com

Jin Medical International Ltd - Ordinary Shares - Class A

July 1, 2026 | money.usnews.com

Jin Medical Plans Major VIE Acquisition and Governance Restructuring Ahead of July 2026 EGM

June 29, 2026 | tipranks.com

Jin Medical International Replaces Audit Alliance With Enrome as Independent Auditor

June 4, 2026 | tipranks.com

Jin Medical Regains Nasdaq Bid-Price Compliance After Reverse Share Split

April 10, 2026 | theglobeandmail.com

Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement

April 7, 2026 | prnewswire.com

Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative

March 11, 2026 | prnewswire.com

Jin Medical Shareholders Approve Dual-Class Structure and Conditional Reverse Splits

February 7, 2026 | theglobeandmail.com

Jin Medical CEO Fireside Chat

February 5, 2026 | prnewswire.com

Jin Medical to Host February 1 Fireside Chat as It Revamps Corporate Website

January 28, 2026 | tipranks.com

Jin Medical International Ltd. To Host Management Fireside Chat

January 26, 2026 | prnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

XTNT, FOCL, ZJYL, and CNXU Company Descriptions

Conexeu Sciences NASDAQ:CNXU

$4.96 -0.34 (-6.42%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$5.20 +0.24 (+4.78%)

As of 09/18/2026 07:30 PM Eastern

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. --- Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property ("IP") developed over more than a decade at the University of British Columbia (the "University") and the BC Professional Firefighters Burn and Wound Healing Laboratory. In November 2023, the Company entered into a patent assignment agreement with the University pursuant to which the Company acquired an assignment of the University's right, title, and interest in the applicable patents and patent applications related to the underlying technology. The Company's only device candidate is the CXU™ scaffold device candidate, which is in preclinical development and has not been approved or cleared for marketing in any jurisdiction. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications. Any potential benefits to patients, providers, or healthcare systems have not been established and will require further study and regulatory review. CXU™ is a temperature-responsive, collagen-based extracellular matrix ("ECM") formulation designed to transition from a liquid to a gel-like scaffold following topical application or injection, typically within approximately ten minutes (the "10 Minute Tissue™" concept). The device IP is protected by issued and pending patents and is being evaluated in preclinical studies for its ability to provide an ECM-like environment associated with cellular infiltration, vascularization, and organized tissue remodeling in non-clinical models. We intend to seek U.S. Food and Drug Administration ("FDA") clearance in the United States for the CXU™ scaffold device candidate through the 510(k) premarket notification process as a Class II medical device; however, the FDA has not yet determined the appropriate classification or regulatory pathway for our device candidate, may require additional data or a different pathway, and there can be no assurance that we will obtain clearance or that the device candidate will become commercially available. Our principal executive offices are located in Reno, Nevada.

FocalTherics NASDAQ:FOCL

$4.15 -0.13 (-3.04%)

As of 09/18/2026 04:00 PM Eastern

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

Xtant Medical NYSEAMERICAN:XTNT

$0.32 -0.01 (-2.14%)

As of 09/18/2026 04:10 PM Eastern

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers Certex spinal fixation, Spider cervical plating, Streamline OCT, CervAlign, Axle interspinous fusion, Xpress minimally invasive pedicle screw, Fortex pedicle screw, Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation systems, and Silex sacroiliac joint fusion systems. Further, it provides Calix for cervical and thoracolumbar applications, as well as Irix-C Cervical Integrated Fusion, Irix-A Lumbar Integrated Fusion, Fortilink, and Irix-A Lumbar integrated fusion systems; Coflex device for lumbar spinal stenosis; and CoFix implant for back and disc pain. The company is headquartered in Belgrade, Montana.

Jin Medical International NASDAQ:ZJYL

$1.99 +0.01 (+0.51%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$1.93 -0.06 (-3.02%)

As of 09/18/2026 07:55 PM Eastern

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest XTNT, FOCL, ZJYL, and CNXU Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest XTNT, FOCL, ZJYL, and CNXU Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

XTNT, FOCL, ZJYL, and CNXU Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

XTNT, FOCL, ZJYL, and CNXU Company Descriptions

Conexeu Sciences NASDAQ:CNXU

FocalTherics NASDAQ:FOCL

Xtant Medical NYSEAMERICAN:XTNT

Jin Medical International NASDAQ:ZJYL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest XTNT, FOCL, ZJYL, and CNXU Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest XTNT, FOCL, ZJYL, and CNXU Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

XTNT, FOCL, ZJYL, and CNXU Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

XTNT, FOCL, ZJYL, and CNXU Company Descriptions

Conexeu Sciences NASDAQ:CNXU

FocalTherics NASDAQ:FOCL

Xtant Medical NYSEAMERICAN:XTNT

Jin Medical International NASDAQ:ZJYL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools